Finance entity
Every one of those 1 sits in a single category, earnings. Of the tracked stories, 1 of 1 also mention Bank of America, the most common co-covered peer. The 5 average consequence score is below the beat benchmark of 6.6 in the same window.
Last mentioned: Mar 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, earnings. Of the tracked stories, 1 of 1 also mention Bank of America, the most common co-covered peer. The 5 average consequence score is below the beat benchmark of 6.6 in the same window. They are less corroborated than the beat average, carrying 2 original sources each against 2.7 for the same window. Richard Bernstein Advisors appears in 1 tracked Finance story from March 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 128 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Richard Bernstein Advisors. Shared-story counts are live from our verified record — not editorial picks.
BofA Target Increase
Bank of America raises price target based on pharmaceutical and MedTech pipeline strength.
Institutional Rebalancing
Richard Bernstein Advisors and Rathbones Group PLC report reduced holdings in JNJ.
Fast-Track Approval
FDA approves Tecvayli-Darzalex combination for blood cancer treatment.
FDA Approval & 12-Month High
JNJ receives FDA approval for multiple myeloma combo and stock hits a yearly peak.
Bank of America has raised its price target for Johnson & Johnson, citing robust growth in the company's pharmaceutical and MedTech pipelines. The upgrade follows a series of FDA approvals and a strategic pivot toward high-margin innovative medicine after the Kenvue spinoff.
Richard Bernstein Advisors is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
